Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025
Express News | Inotiv Inc : Jefferies Cuts Target Price to $1.50 From $3.50
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing
Lake Street Remains a Buy on Inotiv (NOTV)
Lake Street Doesn't Expect Inotiv Financial Impact From FDA 'Headline Noise'
12 Health Care Stocks Moving In Thursday's After-Market Session
Express News | 'FDA Announces Plan to Phase Out Animal Testing Requirement For Monoclonal Antibodies And Other Drugs' - FDA
Inotiv Drops After FDA Says Phasing Out Animal Testing of Monoclonal Antibodies
Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients With CNS Disorders
Inotiv Shareholders Approve Key Governance Decisions
It's Down 37% But Inotiv, Inc. (NASDAQ:NOTV) Could Be Riskier Than It Looks
Top Executives at Inotiv Make Significant Stock Sales!
Craig-Hallum Maintains Inotiv(NOTV.US) With Buy Rating
Express News | Inotiv- Enters Settlement Agreement With Freese and Nichols; They Will Pay Co $7.55 Mln in Settlement
$NOTV Stock Is up 20% Today. Here's What We See in Our Data.
Inotiv, Inc. Earnings Call: Mixed Sentiment Amidst Challenges
Inotiv | 10-Q: Q1 2025 Earnings Report
Craig-Hallum Maintains Inotiv(NOTV.US) With Buy Rating, Announces Target Price $9
Inotiv Price Target Lowered to $9 From $10 at Craig-Hallum
Inotiv, Inc. Reports Q1 2025 Earnings and Strategic Outlook